Clinical Trials in Yuyao, China
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
Marginal Zone Lymphoma (MZL)
Second Affiliated Hospital, School of Medicine, Zhejiang University51 enrolled18 locationsNCT07022223
Recruiting
Phase 3
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Asthma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.660 enrolled74 locationsNCT06829784